Considering the increasing number of reports regarding the neuroprotective effects of GH in several models as well as the beneficial impacts of GH treatment in patients with brain trauma, stroke, spinal cord injury, neurological deficit, and cognitive disfunction, it is necessary to fully understand the molecular mechanisms and cellular interactions underlying these neurotrophic effects [6,7,8,9]. The gene discussed is GH1; the disease is stroke disorder.